IP Library Granted Patent US 10,179,222
Granted Patent B2
US 10,179,222 · App. 14/546,373 · Granted Jan 15, 2019

Delivery of ultra pure nitric oxide (NO)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,222
App. No.
14/546,373
Granted
Jan 15, 2019
Kind
B2
Abstract

A system for delivering a therapeutic amount of nitric oxide can include a reservoir assembly, a gas supply, and a delivery conduit including a first cartridge, wherein the first cartridge can include a surface-activated material saturated with an aqueous solution of a reducing agent. In certain embodiments, the reservoir includes a restrictor.

Claims (20)

1. A method of manufacturing a reservoir assembly for delivering nitric oxide, comprising:

filling a reservoir with a source of nitrogen dioxide, wherein the reservoir is less than 6 inches in height and less than 4 inches in diameter;

forming a restrictor within a metal sheath on the reservoir and a heating element arranged to maintain the temperature of the restrictor and a thermistor, wherein the restrictor is coupled with the reservoir;

connecting the reservoir to a delivery conduit via the restrictor, and connecting the delivery conduit to a gas supply such that a gas from the gas supply and the nitrogen dioxide can mix in the delivery conduit, the delivery conduit including at least one cartridge, the cartridge including an inlet and an outlet and a surface-activated material and a reducing agent therebetween.

2. The method of claim 1 , wherein the restrictor includes a first end and a second end, wherein the first end of the restrictor is coupled the reservoir.

3. The method of claim 2 , further includes sealing the second end of the restrictor.

4. A reservoir assembly, comprising

a reservoir, wherein the reservoir is less than 6 inches in height and less than 4 inches in internal diameter and the reservoir includes a restrictor within a metal sheath on the reservoir and a heating element arranged to maintain the temperature of the restrictor and a thermistor, wherein the restrictor is coupled with the reservoir;

a delivery conduit connected to the reservoir via the restrictor, and the delivery conduit connected to a gas supply such that a gas from the gas supply and the nitrogen dioxide can mix in the delivery conduit, the delivery conduit including at least one cartridge, the cartridge including an inlet and an outlet and a surface-activated material and a reducing agent therebetween.

5. The reservoir assembly of claim 4 , wherein the reservoir is less than 4 inches in height and less than 2 inches in internal diameter.

6. The reservoir assembly of claim 4 , wherein the reservoir is less than 1 inch in height and less than 1 inch in internal diameter.

7. The reservoir assembly of claim 4 , wherein the restrictor has an internal diameter of less than 0.100 microns.

8. The reservoir assembly of claim 4 , wherein the restrictor has an internal diameter of less than 0.050 microns.

9. The reservoir assembly of claim 4 , wherein the restrictor is coupled to the reservoir.

10. The reservoir assembly of claim 4 , wherein the restrictor includes a first end and a second end.

11. The reservoir assembly of claim 4 , wherein the restrictor includes a tube.

12. The reservoir assembly of claim 11 , wherein the tube is a capillary tube.

13. The reservoir assembly of claim 4 , wherein the first end of the restrictor is coupled to the reservoir.

14. The reservoir assembly of claim 4 , wherein the second end of the restrictor is sealed or closed.

15. The reservoir assembly of claim 4 , wherein the reservoir includes a nitrogen dioxide source.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Aug 7, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 048173/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: FINE, DAVID H.; VASQUEZ, GREGORY; JOHNSON, BRYAN; DENTON, RYAN; GAMERO, LUCAS G.
To: GENO LLC
Reel/Frame 035542/0113 →
Cited By (7)
US 12,226,614 US 12,509,349 US 12,522,501 US 12,569,628 US 12,576,234 US 12,605,520 US 12,606,436